Zebrafish as an effective model for evaluating phage therapy in bacterial infections: a promising strategy against human pathogens
Antimicrobial Agents and Chemotherapy · 2024
DOI: 10.1128/aac.00829-24 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Antimicrobial Agents and Chemotherapy, 2024. Verfasst von Lucile Plumet und 4 weiteren Autor:innen. Beteiligte Einrichtung: VBIC, INSERM U1047, University of Montpellier, Montpellier, France. Hauptthemen laut MEDLINE: Zebrafish, Phage Therapy, Bacterial Infections, Disease Models, Animal. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
The escalating prevalence of antibiotic-resistant bacterial infections necessitates urgent alternative therapeutic strategies. Phage therapy, which employs bacteriophages to specifically target pathogenic bacteria, emerges as a promising solution. This review examines the efficacy of phage therapy in zebrafish models, both embryos and adults, which are proven and reliable for simulating human infectious diseases. We synthesize findings from recent studies that utilized these models to assess phage treatments against various bacterial pathogens, including Enterococcus faecalis , Pseudomonas aeruginosa , Mycobacterium abscessus , Staphylococcus aureus , Klebsiella pneumoniae , Acinetobacter baumannii , and Escherichia coli . Methods of phage administration, such as circulation injection and bath immersion, are detailed alongside evaluations of survival rates and bacterial load reductions. Notably, combination therapies of phages with antibiotics show enhanced efficacy, as evidenced by improved survival rates and synergistic effects in reducing bacterial loads. We also discuss the transition from zebrafish embryos to adult models, emphasizing the increased complexity of immune responses. This review highlights the valuable contribution of the zebrafish model to advancing phage therapy research, particularly in the face of rising antibiotic resistance and the urgent need for alternative treatments.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- VBIC, INSERM U1047, University of Montpellier, Montpellier, France.
- Greenphage, Cap Alpha, Clapiers, France.
- VBIC, INSERM U1047, University of Montpellier, Department of Microbiology and Hospital Hygiene, CHU Nîmes, Nîmes, France.
ORCID-Profile: Lucile Plumet, Jean-Philippe Lavigne, Virginie Molle
Zitieren
APA
Plumet, L., Costechareyre, D., Lavigne, J. P., Kissa, K., & Molle, V. (2024). Zebrafish as an effective model for evaluating phage therapy in bacterial infections: a promising strategy against human pathogens. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.00829-24
Vancouver
Plumet L, Costechareyre D, Lavigne JP, Kissa K, Molle V. Zebrafish as an effective model for evaluating phage therapy in bacterial infections: a promising strategy against human pathogens. Antimicrobial Agents and Chemotherapy. 2024. doi:10.1128/aac.00829-24
BibTeX
@article{Plumet2024,
author = {Plumet, Lucile and Costechareyre, Denis and Lavigne, Jean-Philippe and Kissa, Karima and Molle, Virginie},
title = {Zebrafish as an effective model for evaluating phage therapy in bacterial infections: a promising strategy against human pathogens},
journal = {Antimicrobial Agents and Chemotherapy},
year = {2024},
doi = {10.1128/aac.00829-24}
}
EUVIMED